SBRA
Sabra Health Care REIT, Inc.
Real Estate — REIT - Healthcare Facilities
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Buy
2.5 / 5
13 analysts
$19.20
$-0.52 (-2.64%)
Target:
$22.15
(15.4%)
Price History
52-Week Range
Sign in to add SBRA to a watchlist or set price alerts.
Fundamentals
| Market Cap | $4.96B |
| P/E Ratio (TTM) | 31.24 |
| Forward P/E | 26.48 |
| EPS (TTM) | $0.63 |
| Dividend Yield | 6.10% |
| Profit Margin | 19.15% |
| Revenue Growth | 21.70% |
| ROE | 5.68% |
| Debt/Equity | 95.86 |
| Recommendation | Buy 2.5 |
| Analyst Target | $22.15 |
| Analysts | 13 |
| Next Earnings | Aug 3, 2026 AMC |
| Indexes | - |
Technical Indicators
| RSI (14) | 72.8 |
| Beta | 0.63 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $21.28 |
| 52-Week Low | $17.17 |
| 50-Day Avg | $19.74 |
| 200-Day Avg | $19.31 |
| Avg Volume | $2.72M |
| Volume | 46.4K |
Performance Analysis
NEUTRALSBRA presents a mixed picture with both positive and negative indicators.
~
Trading at 49% of its 52-week range.
-
RSI at 72.8 indicates overbought conditions — a pullback may be due.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
+
Strong revenue growth of 21.7% year-over-year.
+
Wall Street consensus is "Buy" from 13 analysts.
+
Average analyst target of $22.15 implies 15.4% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:30 UTC
Back to Screener Export Report